Genes, environment & neural stem cell transplantation in the gut

基因、环境

基本信息

  • 批准号:
    9313244
  • 负责人:
  • 金额:
    $ 36.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-15 至 2018-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Loss of functional enteric neurons results in clinical disorders such as achalasia, gastroparesis, neuropathic forms of pseudoobstruction, enteric neuronal dysplasia, colonic inertia and Hirschsprung's disease. Despite the lack of significant neurogenesis in vivo in these conditions, there is growing evidence to suggest the existence of multipotent neural precursor cells (NPCs) in abundant numbers in the gut. Several investigators including ourselves have shown that these cells, which have some phenotypical markers typical of glia, are capable of robust neurogenesis in vitro. We have now shown that enteric ganglia in longitudinal muscle myenteric plexus (LMMP) preparations display neurogenesis and this is even more pronounced in completely dissociated NPC preparations in culture. We have identified enteric neural precursors in vivo and in vitro and our preliminary studies implicate phosphatase and tensin homolog (PTEN) in these cells as the major "brake" on neurogenesis in vivo. Further collagen IV when added to LMMP preparations can have a profound inhibitory effect on neurogenesis. Thus it is logical to hypothesize that the discrepancy between the in vivo and ex vivo situation can be explained by factors in the microenvironment that regulate PTEN. In this proposal we therefore intend to examine the effects of collagen IV and downstream pathways including integrin, FAK and RhoA/ROCK which may drive PTEN activity, checking enteric neurogenesis in vivo, via the following specific aims: Specific Aim 1: To determine the interactions between extrinsic (collagen) and intrinsic (PTEN) brakes on neurogenesis in health and disease Specific Aim 2: To examine the effects of countering intrinsic and extrinsic brakes on enteric neurogenesis in vivo in health and disease Specific Aim 3: To examine the effects of manipulating selected key components of these pathways on survival and function of allogeneic enteric NSC (ENSC) transplants Our long-term objective is to develop neuronal transplantation as a treatment for human diseases of the enteric nervous system as well as stimulate neural regeneration in these disorders. By establishing a role for PTEN and related pathways the proposed studies will provide the critical groundwork for novel therapeutic interventions.
描述(由申请人提供):功能性肠神经元的丧失导致临床疾病,例如贲门失弛缓症、胃轻瘫、假性梗阻的神经病形式、肠神经元发育不良、结肠惯性和先天性巨结肠。尽管在这些条件下缺乏显着的神经发生在体内,有越来越多的证据表明,在肠道中存在大量的多能神经前体细胞(NPC)。包括我们在内的一些研究人员已经表明,这些细胞具有一些典型的神经胶质细胞表型标记,能够在体外进行强大的神经发生。我们现在已经表明,肠神经节在纵肌肌间神经丛(LMMP)的制剂显示神经发生,这是在完全分离的NPC制剂在文化中更加明显。我们已经确定了肠神经前体在体内和体外,我们的初步研究牵连磷酸酶和张力蛋白同源物(PTEN)在这些细胞中的主要“刹车”在体内神经发生。当加入到LMMP制剂中时,进一步的胶原IV可以对神经发生具有深刻的抑制作用。因此,它是合乎逻辑的假设,体内和离体情况之间的差异可以解释的微环境中的因素,调节PTEN。因此,在本提案中,我们打算通过以下具体目的来检查IV型胶原和下游途径(包括可能驱动PTEN活性的整合素、FAK和RhoA/ROCK)的作用,检查体内肠神经发生:(胶原)和内在(PTEN)对健康和疾病中神经发生的制动为了检查对抗内在和外在制动对健康和疾病中体内肠神经发生的影响,具体目标3:为了检查操纵这些途径的选定关键组分对同种异体肠NSC(ENSC)移植物的存活和功能的影响,术语目的是开发神经元移植作为人类肠神经系统疾病的治疗以及刺激这些疾病中的神经再生。通过建立PTEN和相关通路的作用,拟议的研究将为新的治疗干预提供关键的基础。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Age-associated changes in lineage composition of the enteric nervous system regulate gut health and disease.
  • DOI:
    10.7554/elife.88051
  • 发表时间:
    2023-12-18
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Kulkarni S;Saha M;Slosberg J;Singh A;Nagaraj S;Becker L;Zhang C;Bukowski A;Wang Z;Liu G;Leser JM;Kumar M;Bakhshi S;Anderson MJ;Lewandoski M;Vincent E;Goff LA;Pasricha PJ
  • 通讯作者:
    Pasricha PJ
Ex vivo neurogenesis within enteric ganglia occurs in a PTEN dependent manner.
  • DOI:
    10.1371/journal.pone.0059452
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Becker L;Peterson J;Kulkarni S;Pasricha PJ
  • 通讯作者:
    Pasricha PJ
Simultaneous optical and electrical in vivo analysis of the enteric nervous system.
  • DOI:
    10.1038/ncomms11800
  • 发表时间:
    2016-06-07
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Rakhilin N;Barth B;Choi J;Muñoz NL;Kulkarni S;Jones JS;Small DM;Cheng YT;Cao Y;LaVinka C;Kan E;Dong X;Spencer M;Pasricha P;Nishimura N;Shen X
  • 通讯作者:
    Shen X
Evolving treatment of achalasia: a POEM in motion.
贲门失弛缓症治疗的演变:运动中的 POEM。
  • DOI:
    10.1016/j.gie.2016.04.041
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Ahuja,NitinK;Pasricha,PankajJay
  • 通讯作者:
    Pasricha,PankajJay
White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies.
  • DOI:
    10.1016/j.ydbio.2016.04.001
  • 发表时间:
    2016-09-15
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Burns, Alan J.;Goldstein, Allan M.;Newgreen, Donald F.;Stamp, Lincon;Schaefer, Karl-Herbert;Metzger, Marco;Hotta, Ryo;Young, Heather M.;Andrews, Peter W.;Thapar, Nikhil;Belkind-Gerson, Jaime;Bondurand, Nadege;Bornstein, Joel C.;Chan, Wood Yee;Cheah, Kathryn;Gershon, Michael D.;Heuckeroth, Robert O.;Hofstra, Robert M. W.;Just, Lothar;Kapur, Raj P.;King, Sebastian K.;McCann, Conor J.;Nagy, Nandor;Ngan, Elly;Obermayr, Florian;Pachnis, Vassilis;Pasricha, Pankaj J.;Sham, Mai Har;Tam, Paul;Vanden Berghe, Pieter
  • 通讯作者:
    Vanden Berghe, Pieter
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PANKAJ J PASRICHA其他文献

PANKAJ J PASRICHA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PANKAJ J PASRICHA', 18)}}的其他基金

Validation of peripheral CGRP signaling as a target for the treatment of pain in chronic pancreatitis
验证外周 CGRP 信号作为治疗慢性胰腺炎疼痛的靶标
  • 批准号:
    10764850
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
Alcohol, TRPV1 and Pancreatic Nerves in Pain and Inflammation
酒精、TRPV1 和胰神经在疼痛和炎症中的作用
  • 批准号:
    7936067
  • 财政年份:
    2009
  • 资助金额:
    $ 36.45万
  • 项目类别:
Genes, environment & neural stem cell transplantation in the gut
基因、环境
  • 批准号:
    8926953
  • 财政年份:
    2009
  • 资助金额:
    $ 36.45万
  • 项目类别:
Genes, Environment & Neural Stem Cell Transplantation in the Gut
基因、环境
  • 批准号:
    7585560
  • 财政年份:
    2009
  • 资助金额:
    $ 36.45万
  • 项目类别:
Molecular Approaches to Pathogenesis and Therapy in Human Gastroparesis
人类胃轻瘫发病机制和治疗的分子方法
  • 批准号:
    7905314
  • 财政年份:
    2009
  • 资助金额:
    $ 36.45万
  • 项目类别:
Genes, Environment & Neural Stem Cell Transplantation in the Gut
基因、环境
  • 批准号:
    7886724
  • 财政年份:
    2009
  • 资助金额:
    $ 36.45万
  • 项目类别:
Genes, environment & neural stem cell transplantation in the gut
基因、环境
  • 批准号:
    9098728
  • 财政年份:
    2009
  • 资助金额:
    $ 36.45万
  • 项目类别:
Genes, Environment & Neural Stem Cell Transplantation in the Gut
基因、环境
  • 批准号:
    8094452
  • 财政年份:
    2009
  • 资助金额:
    $ 36.45万
  • 项目类别:
Genes, Environment & Neural Stem Cell Transplantation in the Gut
基因、环境
  • 批准号:
    8293278
  • 财政年份:
    2009
  • 资助金额:
    $ 36.45万
  • 项目类别:
Genes, environment & neural stem cell transplantation in the gut
基因、环境
  • 批准号:
    8818515
  • 财政年份:
    2009
  • 资助金额:
    $ 36.45万
  • 项目类别:

相似海外基金

HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart (HEAL)
HLA-纯合 iPSC-心肌细胞 用于心脏同种异体细胞治疗 (HEAL) 的聚集体制造技术
  • 批准号:
    10039902
  • 财政年份:
    2022
  • 资助金额:
    $ 36.45万
  • 项目类别:
    EU-Funded
Evaluation of the efficacy of LAT1 inhibitor to tumor stroma and immunity in an allogenic mouse model of colon cancer having abundant stroma.
在具有丰富基质的同种异体结肠癌小鼠模型中评估 LAT1 抑制剂对肿瘤基质和免疫的功效。
  • 批准号:
    21K15925
  • 财政年份:
    2021
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanism of kidney injury associated with graft-versus-host disease after allogenic stem cell transplantation
同种异体干细胞移植后移植物抗宿主病相关肾损伤的机制
  • 批准号:
    21K08410
  • 财政年份:
    2021
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clarification of the origin and maintenance mechanisms of junctional epithelium and identification of its stem cells using allogenic tooth germ transplantation
阐明交界上皮的起源和维持机制并利用同种异体牙胚移植鉴定其干细胞
  • 批准号:
    20K21672
  • 财政年份:
    2020
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
The study about the allogenic MSCs transplantation to the cardiac disease models.
同种异体间充质干细胞移植至心脏病模型的研究。
  • 批准号:
    18K16395
  • 财政年份:
    2018
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Artificial nerves containing allogenic basal lamellae scaffold and bone marrow derived stem cells
含有同种异体基底板层支架和骨髓干细胞的人工神经
  • 批准号:
    17K10951
  • 财政年份:
    2017
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
HSP90-α 在保护缺血心脏同种异体间充质干细胞免疫特权中的作用
  • 批准号:
    370541
  • 财政年份:
    2017
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Operating Grants
Attempt to Prefabricate Vascularized Allogenic Bone in Recipient -Use of Cultured Bone Marrow Cells-
尝试在受者体内预制血管化的同种异体骨 - 使用培养的骨髓细胞 -
  • 批准号:
    16K10863
  • 财政年份:
    2016
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
  • 批准号:
    276706135
  • 财政年份:
    2015
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Clinical Trials
Induction of thyme epithelial cells from iPS cells and application to allogenic transplantation
iPS细胞诱导百里香上皮细胞及其在同种异体移植中的应用
  • 批准号:
    15H04915
  • 财政年份:
    2015
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了